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Case Presentations 
CASE I: 
A 43-year-old white male construction worker was admitted to the coronary care unit for evaluation of 
left anterior chest discomfort. 
How would you manage the following intermittent arrhythmia, which was noted shortly after admission? 
Vital signs remained stable. 
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Dr. Baird: Dr. Dreifus, how would you manage this 
patient's arrhythmia? 
Dr. Dreifus: You have here a premature ventricular 
systole which begins a run of slow ectopic beating 
presumably from the ventricle. It is not occurring on 
top of the T wave. The victim is in ventricular tachy-
cardia at a rate of about 60 or 62, and it appears to 
be a slow ventricular idioventricular rate without re-
trograde P waves. In this case I would try speeding up 
the sinus rate with a little atropine to eliminate the 
slow rate. 
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Dr. Baird: Would any other panelists like to comment 
or disagree? 
Dr. Zoll: I would simply watch the patient and do 
nothing else. 
Dr. Parsonnet: In our coronary care unit with con-
tinuous monitoring, this is not an infrequent arrhyth-
mia, though Dr. Samet has just whispered in my ear 
that he sees it rarely in his unit. It is totally benign 
and has no serious consequences, therefore it is not 
treated. 
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CASE II: 
This 75-year-old black male represents an arrhythmia related to digitalis toxicity. 
Is temporary pacing indicated? 
CASE II 
Dr. Baird: This is a frequent problem in city hospitals. 
There is no adequate history available on this patient, 
but apparently he has been taking too much digitalis. 
The question is, if he has atrial fibrillation with high-
degree A-V block, how would you manage him during 
the interim period? 
Dr. Samet: First, how symptomatic is this individual? 
Dr. Baird: He is confused, and he has been nauseated, 
but there has been no evidence of Stokes-Adams 
seizures. He has mild congestive failure. 
Dr. Samet: Well, the rate here is in the low 40's. If he 
is symptomatic with something that would be im-
proved by increased rate, then I would pace him. If 
he is not symptomatic with this arrhythmia, and if I 
felt it was due to digitalis, I would not pace, but stop 
the digitalis and just watch him. One point I want to 
stress is that when high-degree A-V block is a mani-
festation of digitalis toxicity, the administration of 
potassium is inappropriate and may have untoward 
consequences. If this is just complete heart block, then 
the potassium may have no further block-producing 
tendencies. 
Dr. Baird: How do the other panelists feel? Dr. Dreifus, 
are you concerned about pacing a patient who has an 
arrhythmia due to digitalis? 
Dr. Dreifus: I think if he is confused, I would do as 
Dr. Samet stated. The question is whether or not he is 
symptomatic. Now there is some controversy over 
potassium. I would tend to agree that if in the sub-
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junctional regions you give enough potassium or give 
it too fast, you will cause further block. However, 
there is no doubt that potassium will antagonize digi-
talis in the N region of the A-V node and increase 
conduction. If the serum potassium were depressed 
and if I were worrying about causing further depres-
sion, I would then pace the patient and still administer 
potassium. 
Dr. Baird: Thank you. What are the hazards with 
temporary pacing in patients with digitalis-induced 
arrhythmia? What has been your experience in this 
situation? 
Dr. Dreifus: What you are worried about is the me-
chanical stimulation of that catheter number 1 and 2. 
If you induce a propagated response from the pace-
maker on top of T wave in an over-digitalized patient, 
is the ventricle more vulnerable? Yes, the ventricle is 
more vulnerable, and the risk is increased. But with 
proper placement and prophylactic use of agents while 
you are passing the catheter and with great skill and 
few premature ventricular beats, this is really not a 
problem. 
Questioner: What is your attitude toward treating this 
patient with diphenylhydantoin? 
Dr. Dreifus: I don't think diphenylhydantoin would be 
of value in this instance. In the concentrations used 
clinically, we have shown that it increases block in the 
A-V node. If there were ectopic ventricular beats with 
block here, I certainly would avoid drugs and go the 
pacing route. 
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CASE Ill: 
This patient with a permanent pacemaker developed substernal pain and hypotension. 
Would sympathomimetic amines be helpful to restore his blood pressure? 
CASE Ill 
Dr. Baird: Dr. Zoll, how do you feel about the con-
comitant use of sympathomimetic amines in patients 
with pacemakers? 
Dr. Zoll: With the functioning permanent pacemaker 
in place, one would treat hypotension with drugs as if 
the patient were in normal sinus rhythm. As long as 
the pacemaker rate is reasonably rapid, as in this case, 
the appropriate vasoconstrictor agents (i.e., neosyne-
phrine or isoproterenol) can be used. Most of these 
drugs do have a tendency to arouse ectopic activity as 
well as acceleration of dominant rhythm; however, 
with a well-functioning pacemaker, a positive inotropic 
action is not immediately seen. 
Dr. Samet: My first reaction after seeing this tracing 
would be to ask for other leads. While this tracing 
probably represents paced beats followed by a T wave, 
I am not mathematically certain whether or not these 
other beats represent premature beats. I would have 
to see other leads in order to be certain. 
Dr. Baird: I have used this case to suggest that in cer-
tain patients sympathomimetic amines might lower the 
threshold for ventricular fibrillation, and there might 
be instances in which untoward administration of these 
drugs might precipitate ventricular tachyrhythmias. 
Anybody have any comments or experience with this 
situation? Dr. Dreifus? 
Dr. Dreifus: Yes. I learned my lesson on the cardiac 
surgery table where we used a good deal of sym-
pathomimetic amines, particularly isoproterenol. Be-
yond a flow of 3 micrograms per minute of isopro-
terenol, you will get increased ectopic beating that 
could be fatal to the patient. Therefore, it is a matter 
of degree how you use these agents. I don't think we 
can say that they are all good or all bad; we should, 
however, be aware of the dangers and the limitations 
of administration. 
Dr. Zoll: Isoproterenol clearly does arouse and ac-
celerate ventricular pacemakers. There is a definite 
risk with isoproterenol; but if one gives the drug in a 
diluted solution, say 1 or 2 micrograms per minute, 
we can then step it up every several minutes. We 
usually change the dose every 4 or 5 minutes, watch-
ing what is going on all the time. You can keep on 
going until you get either the desired therapeutic effect 
of an increased cardiac output or increased blood pres-
sure. If untoward effects appear (i.e., ectopic beats), 
reduce the dosage or adjust the administration of the 
dosage until no adverse effects are seen. There is no 
real limit as to how much you should give a patient. 
We have given over 30 micrograms per minute of 
isoproterenol to some patients with complete heart 
block, in what I consider to be a safe and effective 
way. On the other hand, some patients might run into 
trouble with a much smaller dose, in which case you 
stop and take care of the situation accordingly. 
Dr. Samet: The arrhythmic effects of the vasoconstric-
tors really have two aspects. One is the direct aspect 
which has been alluded to, and the other is an aspect 
which follows the development of hypertension. That 
is, when one gets the desired effect by overshooting 
the mark, reflex arrhythmias secondary to hyperten-
sion can develop. Which leads me to my next point: 
One of the things we have learned to mistrust is the 
peripheral arterial pressure under these circumstances. 
We have, in a number of instances, obtained hypo-
tensive readings with the usual blood pressure determi-
nation. Because you can readily overshoot the mark, 
we prefer monitoring the arterial pressure interarter-
ially almost routinely when we feel we have to ad-
minister vasopressors. So I warn you not to trust the 
routinely determined blood pressures in these hypo-
tensive patients. 
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CASE IV: 
This 70-year-old white male was admitted for hematologic evaluation when he suddenly developed chest pain 
and acute EKG changes suggestive of diaphragmatic myocardial infarction. Several days later, he was placed 
on oral procainamide to suppress VPC's. However, the following arrhythmia developed. 
CASE IV 
Dr. Baird: Dr. Narula, how would you manage the 
patient in this situation? 
Dr. Narula: This looks to be a very interesting ar-
rhythmia which terminated spontaneously. Because of 
the sudden sinus beat, the possibility of fusion beat is 
less likely. Therefore, I would say it is probably 
another ectopic beat which suppresses the ventricular 
tachyrhythmias and gives the sinus rhythm a chance. 
Dr. Baird: You would give more suppressant drug 
therapy? 
Dr. Narula: Because sinus rhythm is fairly stable in 
this patient, within the normal physiological range, I 
think this patient would require suppressant therapy. 
Dr. Baird: Any other comments? 
Dr. Samet: In this discussion about the treatment of 
cardiac arrest and ventricular arrhythmia, I would 
like to stress that Dr. Zoll and I were just talking 
about a very simple physical mode which does really 
work; we have seen a blow on the chest administered 
by a clinched fist stop ventricular fibrillation; we have 
also seen it restart the heart that was arrested in just 
a few seconds. 
Dr. Parsonnet: I would like to add that as far as 
therapy in the cardiac care unit is concerned, there is 
a tendency to worry about the electrocardiogram and 
forget about the other things happening to the patient. 
For example, a person who has been in the intensive 
care unit for a few days, hypoventilating and getting 
all kinds of drugs, may have serious abnormalities in 
their blood gases and blood electrolytes. Before you 
rush off and start using a lot of other things, I think 
you ought to make sure that you have a normal 
electrolyte balance. Sometimes, by simply directing the 
blood gases or blood electrolytes, you can stop the 
arrhythmias. 
Dr. Dreifus: I agree with Dr. Parsonnet; you have to 
look for other problems. But remember, these ventri-
cular premature beats are bisecting the T wave. In 
other words, the onset is very close to the T wave, and 
vasoconstrictors will respond to drugs like lidocaine 
and procainamide. This repeated occurance in the 
development of fibrillation brings up an interesting 
hiatus in drug therapy: Do we use a drug like pro-
cainamide or lidocaine, which actually decreases fibril-
lation threshold, or do we switch to an agent like 
bretylium? We just might end up treating these ar-
rhythmias with bretylium when they are prefibrillatory 
or fibrillatory. If there are single ventricular premature 
systoles, you may take the lidocaine approach first just 
to get rid of the ectopic beating period. However, if 
they are prefibrillatory, as in this particular record, we 
may be using bretylium in the future . I think you had 
better keep a very close eye on the literature to see 
where we go from here. 
Dr. Baird: Dr. Samet, do you agree with Dr. Dreifus's 
enthusiasm in regard to bretylium? 
Dr. Samet: If we are talking about bretylium as a drug 
of initial approach, I do not agree. However, if we are 
talking about bretylium as a drug to be used when 
others have failed, then I agree emphatically. There 
are side effects with bretylium even in the horizontal 
position which does not make it the drug of initial 
choice. We still rely upon lidocaine, quinidine, pro-
cainamide, etc., but have used bretylium with success on 
a number of occasions. The role of bretylium has to be 
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kept in proper perspective. 
Dr. Richardson: What about procainamide as an in-
citing drug? 
Dr. Baird: Well, that's a point I was trying to empha-
size. Dr. Dreifus, when ventricular tachyrhythmias 
revert spontaneously, doesn't this give you a clue that 
quinidine or procainamide was induced? 
Dr. Dreifus: No. 
Dr. Baird: Do any of the panelists have experience 
with recurrent ventricular fibrillation due to quinidine? 
Our experience is, in a limited number of cases, that 
they do not require defibrillation, but may be con-
trolled with overdrive pacing. 
Dr. Samet: Would you tell us a little more about the 
circumstances developed? I suspect that some of those 
CASE V: 
cases do not represent quinidine sensitivity but inap-
propriate use of quinidine. 
Dr. Baird: That is an important point in determining 
whether it is really a toxic effect, a rate-dependent 
problem, or an effect related to a true sensitivity as 
originally described; but this a point of argument. The 
procainamide was stopped and the patient's ventricu-
lar irritability decreased. He did not require any over-
drive pacing as a technique suppressing drug-induced 
recurrent ventricular tachyrhythmias. 
Dr. Narula: Could it be that the chest pains and the 
ischemic changes disappeared with time and were re-
sponsible for the disappearance of the arrhythmia 
rather than the discontinuance of the procainamide? 
Dr. Baird: No. 
A 2V2-year-old child was in excellent health until he developed a viral illness, which was complicated by 
rapid heart rate. Initial therapy was digitalization to control "PAT." This failed and recurrent bouts of 
"VT" required 350 countershocks ( 100-200 W.S.). 
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CASE V 
Dr. Baird: Here we discuss the advantages and dis-
advantages of pacing. I have just mentioned the fact 
that atrial overdrive for ventricular pacing may control 
a certain arrhythmia. In this case the child, who had 
been in excellent health, developed a flu-like syndrome 
associated with recurrent bouts of tachyrhythmia. 
At first it was thought that these were paraoxysmal 
atrial tachycardia. However, an intra-atrial lead dem-
onstrated clearly dissociation between the atrial activ-
ity and the ventricular rhythm disturbance. The diag-
nosis was made that this was recurrent ventricular 
tachycardia in a child who possibly had some type of 
myocarditis or myocardiopathy. Assuming the diag-
nosis is correct, what would you recommend in the 
way of pacing or drugs to control this particular prob-
lem? The child had been given 350 countershocks by 
the pediatric service for recurrent bouts of ventricular 
tachycardia associated with hypotension. Dr. Dreifus, 
what are your thoughts on this problem? 
Dr. Dreifus: Obviously this is a very difficult situation. 
I have not seen ventricular tachycardia very often in 
children. The use of digitalis here is contraindicated 
under the circumstances. I am not at all convinced 
that this is ventricular tachycardia. It could be junc-
tional with aberrant conduction. Atrial pacing might 
work in this case if you could get the catheter to stay 
in place, but that is tough in a kid. Ventricular pacing 
may also work, but that too is difficult. What I have 
dealt with in children is the use of propranolol and 
quinidine. The problem is getting them to take that 
combination because it tastes terrible. But sometimes 
that will control the ventricular tachycardia. I have 
not used bretylium, but I think that if I had my choice 
after all the electricity that has passed through this 
kid, I might say this is one of the prefibrillatory or 
prerepetitive situations and switch to a drug like 
bretylium rather than push my luck with the other 
depressant agents. 
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Dr. Baird: Before we comment on bretylium, do you 
think there is any clinical trial justification of internal 
defibrillation? 
Dr. Dreifus: I don't know that we could do it in a 
child though we do it in dogs. It takes a lot of hard-
ware, and I am wondering if it would really be prac-
tical in the end. It works, but maybe Mr. Berkovits 
will have some ideas on how to develop the electronics 
to improve it. I would try to solve all problems like 
this pharmacologically rather than on an internal or 
external defibrillation basis. Once the patients are put 
on a prophylactic pharmacological treatment, the ar-
rythmia usually goes away. 
Dr. Baird: Any other comments? After bretylium was 
administered intravenously in this child, acceleration 
of the ventricular rate occurred. Whether continued 
administration of bretylium would have been effective 
as an antiarrhythmia, I don't know. After I had caused 
rate acceleration with the drug, I was no longer asked 
to follow the patient. Dr. Dreifus? 
Dr. Dreifus: Small doses of bretylium do have a ten-
dency to aggravate the arrhythmia. There is no doubt 
about it. There are some electrophysiological reasons 
why this might occur. The trick is to use enough, but 
using bretylium in a kid for a rather unknown prob-
lem is risky. You may have been right to back off. I 
might have tried a large dose. 
Dr. Baird: It has been an enjoyable day and a half. 
I would like to acknowledge the moderators, Drs. 
Richardson* and Drew* as well as the panelists for 
the support and advice required to make this a success-
ful program. 
* DONALD w. DREW, M.D., Director of Cardiology and 
Acting Director of Internal M edicine, Norfolk General 
Hospital, Norfolk, Virginia. 
* DAVID w. RICHARDSON, M .D. , Professor of Medicine, 
The M edical College of Virginia, Richmond, Virginia. 
